LEO 39652 - Atopic Dermatitis

• Research type

  Research Study

• Full title

  LEO 39652 - A Phase I, First-in-Human, Randomised, Single-Blind, Vehicle-Controlled, Single Ascending Dose Trial Evaluating the Safety, Tolerability and Pharmacokinetics in Male Subjects with Atopic Dermatitis and in Healthy Male Subjects of Cutaneous Application of LEO 39652 Cream

• IRAS ID

  127510

• Contact name

  Joseph Chiesa

• Contact email

  joseph.chiesa@covance.com

• Sponsor organisation

  LEO Pharma A/S

• Eudract number

  2013-000070-30

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  13/NW/0217

• Date of REC Opinion

  25 Apr 2013

• REC opinion

  Further Information Favourable Opinion